Unknown

Dataset Information

Serum biomarker panel for disease severity and prognosis in patients with COVID-19.


ABSTRACT:

Background

Coronavirus disease-2019 (COVID-19) has become a worldwide emergency and has had a severe impact on human health. Inflammatory factors have the potential to either enhance the efficiency of host immune responses or damage the host organs with immune overreaction in COVID-19. Therefore, there is an urgent need to investigate the functions of inflammatory factors and serum markers that participate in disease progression.

Methods

In total, 54 COVID-19 patients were enrolled in this study. Disease severity was evaluated by clinical evaluation, laboratory tests, and computed tomography (CT) scans. Data were collected at: admission, 3-5 days after admission, when severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA detection became negative, and composite en

SUBMITTER: Li J 

PROVIDER: S-EPMC9937873 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature